Today Novavax weighed in on the FDA's latest stipulations, noting that postmarketing commitments aren't unusual and are in place for many approved drugs and biologics.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
The most common symptom reported by healthcare workers was fatigue.
In contrast, the proportion who had asthma or severe headache or migraine declined from 2016 to 2022.
Rates of COVID-related professional stress, however, declined throughout the pandemic.
One state, however—New York—reports high activity of influenza-like illness.
Among the 25% of participants in 1 study who said they experienced long-COVID symptoms, 13% reported sleep disorders.
Staff-to-community COVID-19 rates were similar before and after de-escalation (median community rate, 2.6 before and 1.5 after).
On average, workers who received Novavax had 1.7 systemic symptoms, compared with 2.8 in Pfizer recipients.
Children and adolescents were at higher risk for new-onset mild and moderate chronic kidney disease from 2020 to 2023.
Only the monoclonal antibody tocilizumab and convalescent plasma were linked to a higher risk of certain adverse events.
But prison populations remained about the same during the entire crisis.
